Coherent shares surge 10.16% intraday after securing $154M Texas grant for 6-inch InP wafer production.

Coherent shares rise 5.14% premarket after strong Q2 results, data center growth, and production expansion.

Coherent

Coherent Reports Q4 Fiscal 2025 Earnings with Analyst Expectations

JP Morgan Reiterates Overweight on Coherent with Raised Price Target to $245.

Stifel Financial

Stifel Raises Coherent's PT to $235, Maintains Buy Rating

Catalyst<ul> <li>Recent technical signals such as the Long Lower Shadow on multiple dates indicate strong bullish momentum for COHR.</li> <li>Most analysts rate COHR Buy or Strong Buy, showing broad institutional optimism.</li> <li>Positive fundamental factors such as PB-ROE and Asset-MV highlight strong profitability and asset positioning relative to market value.</li></ul>Risk<ul> <li>Fund flows across all order sizes are showing negative trends, indicating reduced investor confidence.</li> <li>Technical indicators suggest a volatile market with an unclear direction, which could lead to unpredictable price swings.</li></ul>

Key Factors

Coherent secured a $14.08 million Texas grant to build a 6-inch InP wafer fabrication plant, marking the world’s first such facility. Coherent reported Q2 FY26 results with a 17.5% revenue increase to $1.69 billion, driven by strong data center and communications demand. Coherent sold its Tools for Materials Processing business to focus on core photonics and communications markets, using proceeds to reduce debt. JPMorgan raised Coherent's price target to $245, citing AI-driven demand, new customer wins, and production efficiency improvements. Coherent shares surged 10.16% intraday following the Texas grant announcement and a 5.14% premarket rise after strong Q2 results.

COHR News